Repare Therapeutics Inc. lost $2.00 per diluted share in fiscal year 2024. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. Over the trailing 12 months, Q4 FY2024 through Q3 FY2025, the same line adds up to a loss of $1.70 per diluted share. The table below carries 6 fiscal years, from 2019 to 2024, and the quarters Repare Therapeutics Inc. has filed alongside them.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was Repare Therapeutics Inc.'s diluted earnings per share in fiscal year 2024?
Repare Therapeutics Inc. lost $2.00 per diluted share in fiscal year 2024.
How fast is Repare Therapeutics Inc.'s diluted earnings per share growing?
Repare Therapeutics Inc. (RPTX) reported a loss of $2.23 per diluted share in fiscal year 2023 and a loss of $2.00 per diluted share in fiscal year 2024. A growth rate is not meaningful here, because the earlier figure was zero or negative.
What is Repare Therapeutics Inc.'s diluted earnings per share over the last twelve months?
Repare Therapeutics Inc. (RPTX) reported a loss of $1.70 per diluted share over the trailing 12 months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.
How has Repare Therapeutics Inc.'s diluted earnings per share changed over the years?
Across the 6 fiscal years this page covers, Repare Therapeutics Inc. (RPTX) diluted earnings per share went from -$17.81 in fiscal year 2019 to -$2.00 in fiscal year 2024.
What was Repare Therapeutics Inc.'s diluted earnings per share in the most recent quarter?
Repare Therapeutics Inc. (RPTX) reported $0.08 in diluted earnings per share in Q3 2025. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Repare Therapeutics Inc. (RPTX) reported on that line in every period on record.
